# Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS

> **NCT06423586** · NA · COMPLETED · sponsor: **Azienda di Servizi alla Persona di Pavia** · enrollment: 44 (actual)

## Conditions studied

- Post-Acute COVID-19 Syndrome
- Irritable Bowel Syndrome
- Abdominal Pain
- Dysbiosis

## Interventions

- **DIETARY_SUPPLEMENT:** Curcuma longa and Boswellia serrata extracts

## Key facts

- **NCT ID:** NCT06423586
- **Lead sponsor:** Azienda di Servizi alla Persona di Pavia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2021-10-01
- **Final completion:** 2022-06-10
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423586, "Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06423586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*